Krajinovic et al. investigated if CYP2E1, NQO1, and MPO variants modify risk in childhood ALL (predominantly B-ALL) [99] and reported that CYP2E1 and NQO1 variants significantly contributed to the risk, but not MPO variant alone. This evidence concerns the gene MPO and acute lymphoblastic leukemia.